REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorios Roman S.A. (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Laboratorios Roman S.A. Profile Updated: June 19, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Laboratorios Roman S.A. is an enterprise based in Colombia. Its main office is in Cartagena. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. It was incorporated on April 18, 1972. It currently has a total number of 2 (2009) employees. The latest financial highlights indicate a net sales revenue increase of 60.95% in 2022. A growth of 3.87% was recorded in its total assets. The net profit margin of Laboratorios Roman S.A. increased by 541.73% in 2022.

Headquarters
Cl. Universidad No.36-70 Br Centro
Cartagena; Bolivar;

Contact Details: Purchase the Laboratorios Roman S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Laboratorios Roman S.A. report to view the information.
Outstanding Shares:
Purchase the Laboratorios Roman S.A. report to view the information.
Registered Capital:
Purchase the Laboratorios Roman S.A. report to view the information.
Incorporation Date:
April 18, 1972
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Laboratorios Roman S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
60.95%
Total operating revenue
60.95%
Operating profit (EBIT)
94.08%
Net Profit (Loss) for the Period
113.24%
Total assets
3.87%
Total equity
17.69%
Operating Profit Margin (ROS)
340.47%
Net Profit Margin
541.73%
Return on Equity (ROE)
7%
Quick Ratio
24.23%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?